JenaValve Appoints Duane Pinto, MD, MPH, as Chief Medical Officer
October 24, 2022 09:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced that...
JenaValve Completes Enrollment in the ALIGN-AR IDE Clinical Trial
September 14, 2022 06:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced the...
JenaValve Raises $100 Million to Advance Trilogy TAVR Solution
August 31, 2022 06:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. (“JenaValve or the “Company”), developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR)...
JenaValve Announces Results from First Commercial Trilogy Heart Valve System Implants in Europe
June 28, 2022 08:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. (“JenaValve” or the “Company”), developer and manufacturer of differentiated transcatheter aortic valve replacement...
JenaValve Appoints Kari Moore as Chief Financial Officer
May 17, 2022 08:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. (“JenaValve or the “Company”), developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR)...
JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited
January 18, 2022 16:04 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc. (“JenaValve” or the “Company”), developer and manufacturer of differentiated transcatheter aortic valve replacement...
JenaValve Announces First European Commercial Implants with the Trilogy™ Heart Valve System
October 18, 2021 16:03 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Oct. 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced the...
JenaValve gibt erste kommerzielle Implantationen des Trilogy™-Herzklappensystems in Europa bekannt
October 18, 2021 16:03 ET
|
JenaValve Technology, Inc.
IRVINE, Kalifornien, Oct. 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., Entwickler und Hersteller von differenzierten Transkatheter-Aortenklappenimplantationssystemen (TAVI) (auch als...
JenaValve Receives IDE Approval to Initiate The ALIGN-AR Pivotal PMA Trial
August 16, 2021 07:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve replacement (TAVR) systems, today announced FDA...
Establishing TAVR for the Treatment of Aortic Regurgitation(1)
June 15, 2021 07:05 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of a novel transcatheter aortic valve replacement (TAVR) system, is pleased to announce...